(Press-News.org) An experimental drug lessens symptoms of a rare form of childhood leukemia and offers significant insight into the cellular development of the disease, according to findings from a new UCSF study. The mouse model research could spearhead the development of new leukemia therapies and paves the way for future clinical trials in humans.
"Although this drug did not produce a cure, it alleviated the symptoms of leukemia as long as the treatment was continued and delayed the development of a more aggressive disease," said senior author Benjamin Braun, MD, PhD, a pediatric cancer specialist at UCSF Benioff Children's Hospital. "Maintaining a clinical remission for as long as we can may help patients who don't have other options, and perhaps will allow us to approach this disease as a chronic, but manageable, condition."
Study results are published in the March 30, 2011, online edition of the journal Science Translational Medicine.
The study focused on a type of leukemia called juvenile myelomonocytic leukemia, or JMML. An aggressive blood cancer usually diagnosed in patients younger than 5, JMML accounts for 1 to 2 percent of all childhood leukemia cases.
The disease develops in the bone marrow and leads to an elevated white blood cell count that interferes with bone marrow's ability to produce healthy red blood cells. The abnormal increase in white blood cells occurs when genetic changes, or mutations, arise in the genes that encode proteins in a cellular signaling network called the Ras pathway. This network, controlled by the Ras protein, is a critical regulator of cell growth and a frequent target of cancerous mutations.
Currently, JMML is curable only through bone marrow transplantation, in which healthy blood stem cells are extracted from a matched donor and intravenously transplanted into the patient. Still, nearly half of patients relapse after undergoing a transplant, and others are not candidates for transplantation because of advanced illness or the lack of a suitable donor, Braun said.
The researchers treated mice genetically engineered to have JMML with a drug that inhibits a signaling protein called MEK. The drug, known as a MEK inhibitor, blocks just one of the many chemical pathways controlled by Ras. Although several pharmaceutical companies already are developing these drugs, this is the first time a MEK inhibitor has been piloted as a treatment for JMML.
Remarkably, within one week of starting treatment, leukemia symptoms in nearly all of the afflicted mice reversed. Specifically, mice that were treated with the MEK inhibitor produced more red blood cells and fewer white blood cells than untreated mice, and the anemia commonly associated with JMML also disappeared.
According to the researchers, a particularly compelling aspect of the findings is that even after treatment, the majority of the animals' blood was still being produced by the mutant cells that previously caused the disease.
"The most striking aspect of our findings was that the treatment helped the mice not by making the cancer cells go away, but by forcing them to act like normal cells, despite their mutation," said first author Natalya Lyubynska, MD, an internal medicine resident at the University of Michigan. Lyubynska completed this research in Braun's lab as a UCSF medical student, with support from the UCSF Helene and Charles Linker Fellowship and was awarded the UCSF Dean's Prize for Outstanding Student Research for this work.
Through the positive effects of treatment, the study also helps clarify the mechanism by which the Ras signaling pathway regulates cell growth and confirms that the MEK protein plays a key role in the development of JMML.
"It appears that Ras causes disease in part by producing an imbalance of the kinds of cells made in the bone marrow, and that inhibiting MEK can reverse that process," Braun said. "We hope one day to improve on these results by finding a way to completely eliminate leukemia cells. At the same time, we are also learning more about how bone marrow makes the right numbers of each type of cell every day."
###
Additional co-authors include Matthew Gorman, MD, Jennifer Lauchle, MD, Wan Xing Hong, Jon Akutagawa and Kevin Shannon, MD, all with the UCSF Department of Pediatrics.
The research was supported by grants from the National Institutes of Health, the Aplastic Anemia and Myelodysplastic Syndrome Foundation, the MPD Foundation, the V Foundation for Cancer Research, the Ronald McDonald House Charities of Southern California/Couples Against Leukemia, the Jeffrey and Karen Peterson Family Foundation and the Frank A. Campini Foundation.
UCSF Benioff Children's Hospital creates an environment where children and their families find compassionate care at the forefront of scientific discovery, with more than 150 experts in 50 medical specialties serving patients throughout Northern California and beyond. The hospital admits about 5,000 children each year, including 2,000 babies born in the hospital. For more information, visit www.ucsfbenioffchildrens.org.
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. More information is available at www.ucsf.edu.
UCSF researchers identify promising new treatment for childhood leukemia
2011-03-31
ELSE PRESS RELEASES FROM THIS DATE:
Using live worms as bait: Voters swayed by interactive 'worm' graph during election debate.
2011-03-31
Research from Royal Holloway, University of London and the University of Bristol calls into question people's ability to form their own judgements about their preferred election candidate after finding voters could be heavily swayed by 'the worm' - a continuous response tracking measure this is increasingly being used in live election debates around the world.
The study "Social Influence in Televised Election Debates: A Potential Distortion of Democracy" is published today (30 March) in the journal PLoS One.
Televised election debates were introduced in the United ...
Horrible Trucking Accident on Indiana Highway Takes Three Lives
2011-03-31
On January 20, Chester Lee Mills Sr. was supposed to bury his wife, who had lost her battle with lung cancer. Instead, Mills was left to mourn the additional loss of his two children who died in a tragic truck accident en route to their stepmother's funeral. Amanda S. Mills, age 25; Logan R. Mills, age 21; and Anthony Suggs, age 25, were travelling to Georgia to attend the funeral when they were hit by a semi-truck after losing control of their car on icy roads. Witnesses said that the tractor-trailer turned over onto the passenger vehicle, pinning the three people in the ...
Scripps Research scientists: Sensory wiring for smells varies among individuals
2011-03-31
LA JOLLA, CA – March 30, 2011 – If, as Shakespeare's Juliet declared, a rose by any other name smells as sweet – to you and to me and to anyone else who sniffs it – then one might assume that our odor-sensing nerve cells are all wired in the same way. Alas, they are not, according to a new study from scientists at The Scripps Research Institute.
The researchers developed a new virus-based technique for highlighting individual nerve pathways, then applied it to the olfactory systems of mice. They found that mouse olfactory neurons send signals to two key processing regions ...
Brain scientists offer medical educators tips on the neurobiology of learning
2011-03-31
Everyone would like MDs to have the best education – and to absorb what they are taught. The lead article in the April 4 issue of the journal Academic Medicine* connects research on how the brain learns to how to incorporate this understanding into real world education, particularly the education of doctors.
"Repetition, reward, and visualization are tried and true teaching strategies. Now, knowing what is happening in the brain will enhance teaching and learning," said Michael J. Friedlander, executive director of the Virginia Tech Carilion Research Institute (www.vtc.vt.edu/research/index.html) ...
California Court Interprets Commercial Insurance Policy, Says Policy Covers Assault and Battery
2011-03-31
A California Court of Appeals case highlights why it is important for business owners to understand their company's insurance policy, especially the exclusions.
A Case in Point
In 2004, Terrell Ford was dining at a restaurant owned by Palmden. During this time, 20 gang members entered the restaurant and caused a disturbance. Shortly thereafter, the argument was brought outside and a fight instigated.
Ford attempted to leave, but the restaurant employees locked the front doors so he exited a back door. He was attacked and severely beaten by gang members and suffered ...
Increasing Motorcycle Safety to Have a Better Ride
2011-03-31
According to the National Highway Traffic Safety Administration, more than 6 million motorcycles are registered in the U.S., which is about 3 percent of all registered vehicles in the country. However, motorcyclists are seriously injured and killed at a much higher rate than their 4-wheeled counterparts, as 11 percent of all highway deaths each year are motorcycle fatalities.
A variety of factors contribute to the high number of motorcycle crashes each year, including:
- Inexperienced riders
- Insufficient training
- Dangerous road conditions
- Low visibility to ...
Clinical trial success for Crohn's disease cell therapy
2011-03-31
Speaking at the UK National Stem Cell Network annual science meeting later today (30 March), Professor Miguel Forte will describe research into a new cell therapy for chronic inflammatory conditions such as Crohn's disease. Patient's own blood cells are used to produce a type of cell – Type 1 T regulatory lymphocyte – that can reduce the extent of the disease.
Professor Forte said "T regulatory lymphocytes are amazing cells – they secrete proteins – cytokines - that dampen down the over active immune response that causes the terrible symptoms of chronic inflammatory diseases ...
Tet further revealed: Studies track protein relevant to stem cells, cancer
2011-03-31
CHAPEL HILL, N.C. – Last year, a research team at the University of North Carolina at Chapel Hill discovered one way the protein Tet 1 helps stem cells keep their pluripotency—the unique ability to become any cell type in the body. In two new studies, the team takes a broad look at the protein's location in the mouse genome, revealing a surprising dual function and offering the first genome-wide location of the protein and its product, 5-hydroxymethylcytosine—dubbed the "sixth base" of DNA.
UNC biochemist Yi Zhang, PhD, whose team conducted the studies, called the findings ...
Consider Bankruptcy to Prevent Foreclosure
2011-03-31
Many homeowners struggling to make ends meet might feel that foreclosure is their only option. They may not realize that there might be a way for them to keep their home -- filing for bankruptcy. A bankruptcy filing is not ideal for every homeowner, but it might be a way to discharge enough other debt to be able to afford to make current their past due home payments.
Although bankruptcy is an admittedly effective solution for some homeowners, allowing them to escape from underneath a mountain of debt and still remain in their homes, it is still a drastic step. Prior ...
Texas Considers Deferred Adjudication for a First DWI Offense
2011-03-31
Texas lawmakers are considering a change to the state's Driving While Intoxicated laws. Under the law change, deferred adjudication would be available for those charged with their first DWI offense.
As proposed, opting for deferred adjudication would result in supervision, treatment and one year of probation. While it seems as though this may not provide a great alternative to current options for someone accused of DWI, the proposed law would also allow for an acquittal of the DWI charge at the end of the probation period if no further offenses are committed.
Speaking ...